Aprea Therapeutics
APRE
APRE
22 hedge funds and large institutions have $5.5M invested in Aprea Therapeutics in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$160K | |
| 2 | +$16.5K | |
| 3 | +$12.1K | |
| 4 |
Morgan Stanley
New York
|
+$12.1K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$138 |
Top Sellers
| 1 | -$558K | |
| 2 | -$41.2K | |
| 3 | -$23K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$4.07K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.89K |